Conflicting results that challenge the prognostic value of PD-L1 [38] can be attributed to the heterogeneity of PD-L1 expression in OSCC tissue samples since PD-L1 is expressed in both tumor and immune cells, but also to difficulties in standardizing PD-L1 IHC evaluation. Here, CD274 is linked to neoplasm.